Efficacy and Safety of Rituximab in Hepatitis B Virus–Associated PLA2R-Positive Membranous Nephropathy

類似資料

• Prognostic value of PLA2R autoimmunity detected by measurement of anti-PLA2R antibodies combined with detection of PLA2R antigen in membranous nephropathy: A single-centre study over 14 years
  著者:: Pourcine, Franck, 等
  出版事項: (2017)
• The Role of PLA2R Antibody in Treatment of Membranous Nephropathy
  著者:: Dahan, Karine, 等
  出版事項: (2017)
• Efficacy of Rituximab in a Patient With Partial Clinical Remission and Persistent Circulating PLA2R-Ab
  著者:: Georges, Elodie, 等
  出版事項: (2019)
• High-Dose Rituximab and Early Remission in PLA2R1-Related Membranous Nephropathy
  著者:: Seitz-Polski, Barbara, 等
  出版事項: (2019)
• Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up
  著者:: Dahan, Karine, 等
  出版事項: (2017)